| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Stevanato Group (NYSE:STVN) raises FY2025 GAAP EPS guidance from $0.49-$0.54 to $0.54-$0.59 vs $0.52 analyst estimate..
Stevanato Group (NYSE:STVN) affirms FY2025 Adj EPS guidance from $0.53-$0.57 to $0.53-$0.57 vs $0.53 analyst estimate. Affirms ...
Stevanato Gr (NYSE:STVN) reported quarterly earnings of $0.13 per share which beat the analyst consensus estimate of $0.10 by 2...
Stevanato Group S.p.A. (NYSE:STVN), a global provider of drug containment, drug delivery, and diagnostic solutions to the pharm...
Stevanato Group (NYSE:STVN) continues to expect revenue in the range of €1,160 million to €1,190 million for FY 2025. Adjusted ...
Stevanato Gr (NYSE:STVN) reported quarterly earnings of $0.11 per share which met the analyst consensus estimate. This is a 22....
